Bdh Industries Ltd. (BSE: 524828) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹253 Cr, it ranks #2,466 by market cap among the 6,137 Indian listed companies on FinBizNet, and #33 of 63 in Pharmaceuticals. At ₹423.65 (as of 25 Oct 2026), the share price is 30.5% below its 52-week high of ₹610.00 and 24.5% above its 52-week low of ₹340.15. The share price is down 11.8% over one year and down 28.2% over three months.
| Current Price | ₹423.65 |
|---|---|
| Market Cap | ₹253 Cr |
| BSE Code | 524828 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 23.2 |
| Return on Equity | 14.84% |
| Return on Assets | 8.74% |
| 52-Week Range | ₹340.15 – ₹610.00 |
| 1-Year Price Change | -11.8% |
| 3-Month Price Change | -28.2% |
| Beta (1Y) | 0.02 |
| Dividend Yield | 1.15% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.bdhind.com |
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally. The company operates through two segments, Pharmaceuticals and Renewable Energy segments. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-ana
1. Pharmaceuticals-This segment engages in the manufacturing of therapeutic formulations covering a range of pharmaceuticals.
1. Pharmaceuticals-99.1% 2. Renewable Energy-0.9%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹55,577 Cr | 35.5 | 34.46% | ₹1,814 Cr | -16.1% |
| Ajanta Pharma Limited | ₹41,591 Cr | 39 | 25.39% | ₹1,626 Cr | +36.3% |
| Emcure Pharmaceuticals Ltd | ₹34,533 Cr | 36.3 | 19.57% | ₹2,580 Cr | +31.1% |
| Piramal Pharma Ltd | ₹26,284 Cr | -79 | -4.00% | ₹2,270 Cr | -1.6% |
| RUBICON RESEARCH LIMITED | ₹24,972 Cr | 97.6 | 19.14% | ₹534 Cr | — |
| Caplin Point Laboratories Ltdte | ₹17,484 Cr | 26.9 | 19.94% | ₹610 Cr | +10.3% |
| Pfizer Ltd. | ₹17,448 Cr | 24.1 | 17.16% | ₹653 Cr | -32.1% |
| Eris Lifesciences Ltd | ₹15,877 Cr | 24.8 | 18.07% | ₹873 Cr | -30.8% |
| Bdh Industries Ltd. | ₹253 Cr | 23.2 | 14.84% | — | -11.8% |
Listed by market capitalisation. Ratios are shown for context only.
Bdh Industries Ltd. is trading at ₹423.65, with a market capitalisation of ₹253 Cr.
Bdh Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Bdh Industries Ltd. has a P/E of 23.2 and a return on equity of 14.84%.
Bdh Industries Ltd. is listed on the BSE under the scrip code 524828.
Bdh Industries Ltd.'s share price is down 11.8% over one year and down 28.2% over three months. Its 52-week range is ₹340.15 to ₹610.00.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.